JANUS HENDERSON GROUP PLC - 30 Sep 2025 SCHEDULE 13G/A Report for LIGAND PHARMACEUTICALS INCORPORATED Common Stock (LGND)

Filing Manager: JANUS HENDERSON GROUP PLC
Reporting Manager: JANUS HENDERSON GROUP PLC
Security: LIGAND PHARMACEUTICALS INCORPORATED Common Stock
Symbol: LGND
Shares outstanding: 19.7M shares
Disclosed Ownership: 1.04M shares
Ownership: 5.3%
Form type: SCHEDULE 13G/A
Filing time: 14 Nov 2025, 12:43:41 UTC
Date of event: 30 Sep 2025
Previous filing: 14 Aug 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
JANUS HENDERSON GROUP PLC	5.3%	1.04M	0	1.04M	Kristin Mariani	Head of North America Compliance, CCO